Oncology Topic Homepage

Learning Zones

,CLL Knowledge Centre and CME

The CLL Knowledge Centre and CME provide healthcare professionals with important information to aid the treatment and management of patients with the disease. Content is arranged within four main areas: Disease awareness, Events, Resources and CME.

Healthcare professionals will find sections on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment, management, an upcoming events calendar and useful external links.

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ allows you to read case studies and improve your knowledge of CLL by answering quiz questions based on a variety of scenarios. This module has been EACCME-accredited and is worth 1 European CME credit. There is no cost to complete this educational activity.

,Prostate Cancer Learning Hub

Prostate cancer is the third most frequently diagnosed cancer in Europe and the most common cancer among European men,1 making it a major cause of morbidity. Risk factors for prostate cancer include, increasing age, genetic susceptibility, glucose intolerance and environmental factors.2

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer.

The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer. In addition access to editorials of key journal publications, an events calendar, video channel, patient materials and interactive healthcare professionals tools are also available.

References

  1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-1403. EUCAN fact sheet. Estimated incidence, mortality & prevalence, 2012.
  2. Tewari R, Rajender S, Natu SM et al. Diet, obesity, and prostate health: are we missing the link? J Androl 2012;33:763-776.

     

Clinical Case Studies

Non-Small Cell Lung Cancer (NSCLC)

Respiratory Medicine & Allergy: Lung Cancer

Suma Kumar, Guy's and St Thomas' NHS Foundation Trust, London, UK
Richard Leach, Consultant Respiratory Physicians, Guy's and St Thomas' NHS Foundation Trust, London, UK

Case History
A 68-year-old man presented with a four-week history of left-sided, dull, aching chest pain. He had known ischaemic heart disease, previous coronary artery bypass grafting, chronic obstructive pulmonary disease and treated duodenal ulceration.

Sarcoidosis (Radiographic Stage I)

Respiratory Medicine & Allergy: Non granuloma interstitial lung disease

Anne Collett, Consultant Respiratory Physicians, Guy's and St Thomas' NHS Foundation Trust, London, UK
Richard Leach, Consultant Respiratory Physicians, Guy's and St Thomas' NHS Foundation Trust, London, UK

Case History
A 35-year-old male Caucasian barrister presented with a four-week history of dry cough, breathlessness and fatigue. There was no past medical history.

Latest News

Blog

Overdiagnosis is the diagnosis of disease that will cause neither morbidity nor mortality during a patient’s lifetime. Doctors are trained to listen, examine, test, diagnose and treat patients, but we are not warned of the possible dangers of “diseases”, the diagnosis of which will not benefit the patient and may also lead to harm. I would argue the Hippocratic oath, in particular “Primum non nocere” (first, do no harm) should be at the forefront of every clinician’s mind when seeing patients. 

In this blog, I shall outline precisely what overdiagnosis is, why it is important and why we all need to take note of this crisis in healthcare. 

Medical Videos

New Developments in the Treatment of Breast Cancer
New Developments in the Treatment of Breast Cancer
In the podcast, Dr. Crawford describes current and upcoming options available to urologists for treating this group of patients.
In the podcast, Dr. Crawford describes current and upcoming options available to urologists for treating this group of patients.
Metastatic Breast Cancer - A Patient's View of Various Treatments Including Eribulin
Metastatic Breast Cancer - A Patient's View of Various Treatments Including Eribulin
Eribulin Trial Success
Eribulin Trial Success
Surviving Advanced Breast Cancer
Surviving Advanced Breast Cancer
An Overview of Pancreatic NET and the Available Treatments
An Overview of Pancreatic NET and the Available Treatments
Cancer Vaccines- Dr. Kelvin Lee
Cancer Vaccines- Dr. Kelvin Lee
HPV Vaccine
HPV Vaccine
An Animation Explaining the Development of Lymphoma
An Animation Explaining the Development of Lymphoma

Recent Drug Updates

Medical Journal Abstracts on Oncology

Imatinib: a breakthrough of targeted therapy in cancer.

Thu 19 May 2016 -  Imatinib: a breakthrough of targeted therapy in cancer.

Deregulated protein tyrosine kinase activity is central to the pathogenesis of human cancers. Targeted therapy in the form of selective tyrosine kinase inhibitors (TKIs) has transformed the approach ...

In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab.

Tue 03 May 2016 -  In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab.

Background: Eribulin mesylate (eribulin) is a first-in-class halichondrin B-based microtubule dynamics inhibitor. To compare the anti-angiogenic activity of eribulin to that of bevacizumab, we ...

Medical Images

Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer (NSCLC)
Hematoxylin and eosin stain
Hematoxylin and eosin stain
Hypersensitivity Pneumonitis
Hypersensitivity Pneumonitis
Small Cell Lung Cancer (SCLC)
Small Cell Lung Cancer (SCLC)
Amiodarone Pulmonary Toxicity
Amiodarone Pulmonary Toxicity
Sarcoidosis - radiograph showing interstitial shadowing
Sarcoidosis - radiograph showing interstitial shadowing
Pulmonary nodule
Pulmonary nodule
Bronchogenic cyst
Bronchogenic cyst
Sarcoidosis - chest radiograph
Sarcoidosis - chest radiograph

Clinical Guidelines

Guidelines on Testicular Cancer

Mar 2016

The aim of these guidelines is to present the current evidence for the diagnosis and treatment of..

... patients with cancer of the testis. Testicular cancer represents 5% of urological tumours affecting mostly younger males. This document addresses germ-cell tumours and sex cord/gonadal stromal tumours.

Guidelines on Upper Urinary Tract Urothelial Cell Carcinomas

Mar 2016

The European Association of Urology (EAU) Non-muscle-invasive Bladder Cancer (NMIBC) Guidelines..

... Panel has compiled these clinical guidelines to provide urologists with evidence-based information and recommendations for the management of urothelial carcinoma of the upper urinary tract (UTUC).

Online CME

Treatment Optimisation in Chronic Lymphocytic Leukaemia

A new CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been added to the CLL Knowledge Centre on epgonline.org. Read case studies and improve your knowledge of CLL by...

Challenges and Best Practices in the Use of Radionuclide Therapy in mCRPC

This activity is intended for radiation oncologists, medical oncologists, nuclear medicine specialists, urologists, and other clinicians who comprise the team of interprofessionals caring for men with metastatic castration-resistant prostate cancer....

Managing the side effects of treatment for prostate cancer - in association with Prostate Cancer UK

"After you have completed this module you should: Know what the acute and chronic side effects of treatment for prostate cancer are Understand why side effects occur Know how to...

Clinical Trials

Oral THU-Decitabine + Nivolumab for Advanced Non-Small Cell Lung Cancer

-30 days ago

This study looks at the effect of three drugs on lung cancer tumors. This study includes two groups of patients randomized to either Nivolumab, which is the standard of care for this lung cancer, or ...

A Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma

today

The goal of this clinical research study is to learn if Alimta (pemetrexed) can help to control urothelial cancer. The safety of this drug will also be studied. Researchers will also study how a ...

Back to top